tert-Butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate

Catalog No. :
ACOHGU061
CAS No. :
1197294-84-0
Molecular Formula :
C15H21N3O3
Molecular Weight :
291.35

IUPAC Name:tert-butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$149.00Login to see priceIn stockInquiry
250mg97%$251.00Login to see priceIn stockInquiry
1g97%$675.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate
MDL No.MFCD24470511
Molecular FormulaC15H21N3O3
Molecular Weight291.35
SMILESO=C(N1CCN(C2=CC=C(C=O)N=C2)CC1)OC(C)(C)C
InChI KeyZDLAEYGQLPLNTP-UHFFFAOYSA-N
Synonymtert-Butyl 4-(6-formylpyridin-3-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(6-formyl-3-pyridinyl)-, 1,1-dimethylethyl ester;5-(4-Boc-1-piperazinyl)picolinaldehyde
CAS No.1197294-84-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P403+P233-P501

Synthetic Route by SureRoute

1. ACOHGU061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOHGU061 route product structure diagram
    ACOHGU0611197294-84-0 In Stock
Inquiry

2. ACOHGU061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACZNPK906 route compound structure diagram
    ACZNPK90631181-88-1 In Stock
  4. Then
  5. ACOHGU061 route product structure diagram
    ACOHGU0611197294-84-0 In Stock
Inquiry

Comments (0)